ChemicalBook > CAS DataBase List > Tacrolimus Ring-opening Impurity

Tacrolimus Ring-opening Impurity

Product Name
Tacrolimus Ring-opening Impurity
CAS No.
1393890-33-9
Chemical Name
Tacrolimus Ring-opening Impurity
Synonyms
CJ99AS37NC;UNII-CJ99AS37NC;tacrolimus ring opening;Tacrolimus impurity F, EP;Tacrolimus Ring-opening Impurity;Tacrolimus Ring-opening Impurity 1;Tacrolimus Impurity 14(Tacrolimus EP Impurity F)(Tacrolimus Ring-opening Impurity);(3S,4R,5S,8R,12S,14S,15R,16S,18R,26aS,Z)-8-Allyl-5,15-dihydroxy-3-((E)-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl)-14,16-dimethoxy-4,10,12,18-tetramethyl-5,6,11,12,13,14,15,16,17,18,24,25,26,26a-tetradecahydro-3H-pyrido[2,1-c][1]oxa[4]azacyclotricosine-1,7,19,20,21(4H,8H,23H)-pentaone;3H-Pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,19,20,21(4H,8H,23H)-pentone, 5,6,11,12,13,14,15,16,17,18,24,25,26,26a-tetradecahydro-5,15-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-, (3S,4R,5S,8R,9E,12S,14S,1...
CBNumber
CB74842805
Molecular Formula
C44H69NO12
Formula Weight
804.03
MOL File
1393890-33-9.mol
More
Less

Tacrolimus Ring-opening Impurity Property

Boiling point:
873.1±75.0 °C(Predicted)
Density 
1.17±0.1 g/cm3(Predicted)
pka
13.76±0.70(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

Tacrolimus Ring-opening Impurity Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Tacrolimus Ring-opening Impurity Suppliers

Equilife Laboratories Private Limited
Tel
--
Fax
--
Country
India
ProdList
47
Advantage
58
SynZeal Research Pvt Ltd
Tel
--
Fax
--
Email
standards@synzeal.com
Country
India
ProdList
6514
Advantage
58
Pharmaffiliates Analytics and Synthetics P. Ltd
Tel
--
Fax
--
Email
mktg@pharmaffiliates.com
Country
India
ProdList
6739
Advantage
58

1393890-33-9, Tacrolimus Ring-opening ImpurityRelated Search:


  • Tacrolimus Ring-opening Impurity
  • Tacrolimus Impurity 14(Tacrolimus EP Impurity F)(Tacrolimus Ring-opening Impurity)
  • tacrolimus ring opening
  • 3H-Pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,19,20,21(4H,8H,23H)-pentone, 5,6,11,12,13,14,15,16,17,18,24,25,26,26a-tetradecahydro-5,15-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-, (3S,4R,5S,8R,9E,12S,14S,1...
  • (3S,4R,5S,8R,12S,14S,15R,16S,18R,26aS,Z)-8-Allyl-5,15-dihydroxy-3-((E)-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl)-14,16-dimethoxy-4,10,12,18-tetramethyl-5,6,11,12,13,14,15,16,17,18,24,25,26,26a-tetradecahydro-3H-pyrido[2,1-c][1]oxa[4]azacyclotricosine-1,7,19,20,21(4H,8H,23H)-pentaone
  • CJ99AS37NC
  • UNII-CJ99AS37NC
  • Tacrolimus impurity F, EP
  • Tacrolimus Ring-opening Impurity 1
  • 1393890-33-9